Skip to main content

The fallacy of single-agent chemotherapy for cancer.

Publication ,  Journal Article
Friedman, HS; Maxwell, J
Published in: J Clin Oncol
August 10, 2007

Duke Scholars

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

August 10, 2007

Volume

25

Issue

23

Start / End Page

3550

Location

United States

Related Subject Headings

  • Temozolomide
  • Sensitivity and Specificity
  • Promoter Regions, Genetic
  • Oncology & Carcinogenesis
  • O(6)-Methylguanine-DNA Methyltransferase
  • Humans
  • Glioblastoma
  • Dacarbazine
  • Brain Neoplasms
  • Biomarkers, Tumor
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Friedman, H. S., & Maxwell, J. (2007). The fallacy of single-agent chemotherapy for cancer. J Clin Oncol, 25(23), 3550. https://doi.org/10.1200/JCO.2007.12.3596
Friedman, Henry S., and Jill Maxwell. “The fallacy of single-agent chemotherapy for cancer.J Clin Oncol 25, no. 23 (August 10, 2007): 3550. https://doi.org/10.1200/JCO.2007.12.3596.
Friedman HS, Maxwell J. The fallacy of single-agent chemotherapy for cancer. J Clin Oncol. 2007 Aug 10;25(23):3550.
Friedman, Henry S., and Jill Maxwell. “The fallacy of single-agent chemotherapy for cancer.J Clin Oncol, vol. 25, no. 23, Aug. 2007, p. 3550. Pubmed, doi:10.1200/JCO.2007.12.3596.
Friedman HS, Maxwell J. The fallacy of single-agent chemotherapy for cancer. J Clin Oncol. 2007 Aug 10;25(23):3550.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

August 10, 2007

Volume

25

Issue

23

Start / End Page

3550

Location

United States

Related Subject Headings

  • Temozolomide
  • Sensitivity and Specificity
  • Promoter Regions, Genetic
  • Oncology & Carcinogenesis
  • O(6)-Methylguanine-DNA Methyltransferase
  • Humans
  • Glioblastoma
  • Dacarbazine
  • Brain Neoplasms
  • Biomarkers, Tumor